product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Anti-rat IgG (H+L), (Alexa Fluor 647 Conjugate)
catalog :
4418
conjugate :
nonconjugated
more info or order :
Cell Signaling Technology product webpage
citations: 3
Reference
Chaudhary P, Thamake S, Shetty P, Vishwanatha J. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies. Br J Cancer. 2014;111:2328-41 pubmed publisher
Rebhandl S, Huemer M, Zaborsky N, Gassner F, Catakovic K, Felder T, et al. Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia. Eur J Immunol. 2014;44:2175-87 pubmed publisher
Ashley J, Shi Z, Zhao H, Li X, Kesterson R, Feng X. Genetic ablation of CD68 results in mice with increased bone and dysfunctional osteoclasts. PLoS ONE. 2011;6:e25838 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.